PortfoliosLab logoPortfoliosLab logo
ISIN
US46138E7013
CUSIP
73936Q629
IPO Date
Jan 30, 2008

Highlights

EPS (TTM)
$1.78
PE Ratio
0.63
PEG Ratio
0.00
Total Revenue (TTM)
$81.32M
Gross Profit (TTM)
$3.68M
EBITDA (TTM)
$6.00M
Year Range
$0.78 - $285.44
ROA (TTM)
25.01%
ROE (TTM)
32.38%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Haoxi Health Technology Limited

Performance

HAO Performance Chart

Haoxi Health Technology Limited (HAO) is down 99.2% since the beginning of the year. At $1 per share, HAO is trading 99.6% below its 52-week high of $285.


Loading charts...

S&P 500 Index

Returns By Period

Haoxi Health Technology Limited (HAO) has returned -99.18% so far this year and -99.24% over the past 12 months.


Haoxi Health Technology Limited

1D
-5.08%
1M
-16.42%
YTD
-99.18%
6M
-99.12%
1Y
-99.24%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HAO Monthly Returns History

Based on dividend-adjusted daily data since Jan 26, 2024, HAO's average daily return is -0.77%, while the average monthly return is -12.23%.

Historically, 30% of months were positive and 70% were negative. The best month was Jan 2024 with a return of +80.0%, while the worst month was May 2026 at -98.9%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 7 months.

On a daily basis, HAO closed higher 44% of trading days. The best single day was Jan 30, 2024 with a return of +62.4%, while the worst single day was May 11, 2026 at -93.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202628.97%-6.88%-20.62%-28.92%-98.87%6.67%-99.18%
2025-37.87%-22.53%-29.81%0.24%19.69%-14.47%4.62%-13.68%2.21%-5.00%-6.14%-0.00%-71.47%
202480.00%-5.88%-15.83%21.12%-1.23%-26.34%-21.35%-20.95%-89.15%-42.10%-37.17%14.50%-96.47%

Benchmark Metrics

Haoxi Health Technology Limited has an annualized alpha of -88.20%, beta of 0.98, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since January 26, 2024.

  • This stock participated in 172.91% of S&P 500 Index downside but only -189.86% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-88.20%
Beta
0.98
0.01
Upside Capture
-189.86%
Downside Capture
172.91%

Return for Risk

Risk / Return Rank

HAO ranks 3 for risk / return — in the bottom 3% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


HAO Risk / Return Rank: 33
Overall Rank
HAO Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
HAO Sortino Ratio Rank: 33
Sortino Ratio Rank
HAO Omega Ratio Rank: 11
Omega Ratio Rank
HAO Calmar Ratio Rank: 11
Calmar Ratio Rank
HAO Martin Ratio Rank: 00
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Haoxi Health Technology Limited (HAO) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HAOBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.75

Sortino ratioReturn per unit of downside risk

-4.75

Omega ratioGain probability vs. loss probability

0.66

1.37

-0.71

Calmar ratioReturn relative to maximum drawdown

-1.00

2.78

-3.78

Martin ratioReturn relative to average drawdown

-2.40

12.44

-14.84

Dividends

Dividend History


Haoxi Health Technology Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Haoxi Health Technology Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Haoxi Health Technology Limited was 100.00%, occurring on Jun 5, 2026. The portfolio has not yet recovered.

The current Haoxi Health Technology Limited drawdown is 100.00%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-100.00%Jun 2026
2y 1mo
2y 1moMay 2024 - now
2024 bear market2024
-49.18%Apr 2024
1mo 18d24d
2mo 12dFeb 2024 - May 2024
2024 correction2024
-13.97%Feb 2024
2d13d
15dJan 2024 - Feb 2024
2024 pullback2024
-9.85%Jan 2024
0s1d
1dJan 2024 - Jan 2024

Drawdown Indicators


HAOBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-56.78%

-43.22%

Max Drawdown (1Y)

Largest decline over 1 year

-99.57%

-9.10%

-90.47%

Max Drawdown (3Y)

Largest decline over 3 years

-18.90%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-100.00%

-1.80%

-98.20%

Average Drawdown

Average peak-to-trough decline

-81.45%

-10.71%

-70.74%

Ulcer Index

Depth and duration of drawdowns from previous peaks

41.27%

2.03%

+39.24%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Haoxi Health Technology Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Haoxi Health Technology Limited is priced in the market compared to other companies in the Advertising Agencies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for HAO, comparing it with other companies in the Advertising Agencies industry. Currently, HAO has a P/E ratio of 0.6. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for HAO compared to other companies in the Advertising Agencies industry. HAO currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HAO relative to other companies in the Advertising Agencies industry. Currently, HAO has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with HAO

Add Haoxi Health Technology Limited to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with HAO